▁Chron 10.375
ic 5.515625
▁pain 11.6953125
▁is 5.51953125
▁still 6.25390625
▁considered 5.0234375
▁to 1.7294921875
▁be 0.451904296875
▁an 3.009765625
▁extreme 5.953125
▁issue 7.390625
▁among 7.3359375
▁at 6.82421875
▁least 1.4130859375
▁ 2.650390625
8 3.197265625
% 4.3125
▁of 1.8544921875
▁the 1.2421875
▁residents 6.89453125
▁of 2.296875
▁progress 9.40625
ive 0.99169921875
▁countries 6.90625
. 2.11328125
▁The 2.5078125
▁introduction 7.234375
▁of 0.25830078125
▁the 1.607421875
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0625
▁link 6.33203125
▁between 0.53515625
▁pain 6.2734375
▁and 0.7490234375
▁dem 8.375
oral 3.49609375
ization 0.27978515625
. 1.45703125
▁The 1.51953125
▁research 3.7265625
▁investig 5.91015625
ates 0.361083984375
▁the 0.49560546875
▁development 6.16015625
▁of 0.232666015625
▁de 4.50390625
pression 0.285888671875
▁and 1.3623046875
▁anx 2.595703125
iety 0.006683349609375
▁among 2.255859375
▁patients 3.4609375
▁receiving 4.09765625
▁ph 6.77734375
arma 1.9140625
ce 0.006195068359375
ut 0.0002999305725097656
ical 0.01611328125
▁op 4.1796875
io 0.1900634765625
ids 0.80908203125
▁and 2.474609375
▁medical 5.91796875
▁mar 0.96826171875
iju 0.034637451171875
ana 0.00017642974853515625
▁( 4.3828125
MM 0.95751953125
) 3.708984375
▁as 2.87890625
▁severe 9.953125
▁pain 1.50390625
kill 3.12109375
ers 0.0018625259399414062
. 0.55615234375
▁Chron 6.0
ic 0.0155487060546875
▁pain 0.424560546875
▁is 1.2568359375
▁always 6.64453125
▁accompanied 2.25390625
▁by 0.05682373046875
▁negative 4.8671875
▁emot 1.4296875
ional 1.2353515625
▁experiences 3.197265625
▁and 2.07421875
▁blocks 11.1328125
▁a 4.40234375
▁person 1.501953125
’ 24.921875
s 2.419921875
▁ability 1.865234375
▁to 0.0421142578125
▁receive 5.66015625
▁joy 4.9140625
▁and 1.384765625
▁satisfaction 3.33203125
▁from 1.265625
▁life 0.85107421875
. 0.260009765625
▁It 3.57421875
▁comp 8.4296875
ares 4.25390625
▁the 0.68017578125
▁effic 6.01171875
acy 0.00731658935546875
▁of 0.21826171875
▁pres 4.8203125
cri 1.8486328125
ptions 0.80029296875
▁and 2.380859375
▁exam 7.3984375
ines 0.0224151611328125
▁the 0.462646484375
▁possibility 3.83203125
▁of 0.1075439453125
▁post 7.3125
- 0.83447265625
tre 2.697265625
at 0.03021240234375
ment 0.0081787109375
▁de 1.9912109375
pression 0.0914306640625
. 1.6875
▁There 5.17578125
▁is 0.69921875
▁currently 5.0390625
▁a 1.2216796875
▁severe 5.09765625
▁lack 3.18359375
▁of 0.034271240234375
▁information 2.33984375
▁about 1.5908203125
▁the 0.6181640625
▁effects 3.37109375
▁of 0.08026123046875
▁op 1.955078125
i 4.05859375
ates 0.331298828125
. 3.611328125
▁A 3.865234375
▁more 5.39453125
▁manage 8.8359375
able 0.004756927490234375
▁and 2.142578125
▁sa 2.423828125
fer 0.00215911865234375
▁alternative 1.90625
▁might 5.24609375
▁be 0.3359375
▁medical 2.21875
▁mar 0.34130859375
iju 0.016571044921875
ana 0.0007276535034179688
. 0.84716796875
▁They 5.7109375
▁manage 8.1796875
▁pain 2.953125
▁successfully 5.40625
, 1.875
▁but 1.2333984375
▁the 2.716796875
▁past 8.5234375
▁few 3.439453125
▁dec 1.5908203125
ades 0.0003643035888671875
▁indicated 9.0390625
▁the 2.232421875
▁growing 4.7421875
▁concern 4.6328125
▁regarding 2.640625
▁op 2.763671875
iate 0.9482421875
▁ab 2.060546875
use 0.0201873779296875
▁in 3.119140625
▁forms 11.5
▁of 0.47119140625
▁over 3.52734375
d 0.5400390625
ose 0.2109375
▁and 0.8232421875
▁add 1.6884765625
iction 0.0223236083984375
. 0.2161865234375
▁However 4.47265625
, 0.01419830322265625
▁the 1.564453125
▁legal 6.09375
▁status 2.138671875
▁and 2.974609375
▁novel 8.4453125
ty 0.88671875
▁of 0.247314453125
▁this 2.9921875
▁drug 3.07421875
▁do 5.23828125
▁not 0.1614990234375
▁allow 1.8291015625
▁finding 8.6875
▁a 1.9814453125
▁large 5.58984375
▁number 1.5390625
▁of 0.012481689453125
▁studies 1.7783203125
▁on 1.5341796875
▁its 1.3017578125
▁effect 2.517578125
iveness 0.449462890625
. 0.94580078125
▁Specifically 7.58984375
, 0.11859130859375
▁it 2.783203125
▁concerns 5.32421875
▁the 0.75634765625
▁emot 6.69140625
ional 0.0247650146484375
▁condition 5.51171875
▁of 0.369873046875
▁patients 0.8564453125
▁experien 5.9609375
cing 0.0004353523254394531
▁chron 1.451171875
ic 0.0031909942626953125
▁pain 0.135498046875
. 0.9501953125
▁This 3.251953125
▁research 3.20703125
▁paper 5.3046875
▁a 3.078125
ims 0.0017423629760742188
▁to 0.09002685546875
▁analyze 3.447265625
▁levels 9.734375
▁of 0.039215087890625
▁de 0.87255859375
pression 0.031707763671875
▁and 0.494384765625
▁anx 0.07086181640625
iety 0.0024890899658203125
▁among 0.79345703125
▁people 3.033203125
▁receiving 0.9736328125
▁ther 8.0625
apy 0.495849609375
▁by 4.96875
▁comparing 7.60546875
▁the 1.1259765625
▁effects 2.0859375
▁of 0.035888671875
▁ph 2.69140625
arma 0.04766845703125
ce 0.002872467041015625
ut 7.808208465576172e-05
ical 0.0150909423828125
▁op 0.435302734375
io 0.171630859375
ids 0.07708740234375
▁and 0.312744140625
▁MM 2.138671875
. 1.12890625
▁The 1.76171875
▁study 2.44921875
▁was 3.322265625
▁conducted 1.01171875
▁in 1.822265625
▁the 1.6533203125
▁form 2.0859375
▁of 0.01212310791015625
▁collection 9.625
▁and 1.7998046875
▁analysis 1.0380859375
▁of 0.08251953125
▁statistical 4.30859375
▁data 0.2313232421875
. 1.072265625
▁Part 5.84375
icip 0.185302734375
ants 0.07318115234375
▁were 1.021484375
▁rec 3.74609375
ru 0.0008134841918945312
ited 8.106231689453125e-05
▁for 3.537109375
▁six 7.23046875
▁months 0.767578125
▁at 3.568359375
▁two 2.748046875
▁major 5.140625
▁pain 2.099609375
▁relief 4.6796875
▁cent 1.50390625
ers 0.12005615234375
▁in 0.8134765625
▁Israel 4.08203125
. 0.407470703125
▁To 5.4296875
▁specifically 9.75
▁evaluate 3.6875
▁and 4.15234375
▁compare 0.96435546875
▁the 0.413818359375
▁prob 11.34375
abilities 0.88818359375
▁of 0.1700439453125
▁de 1.1513671875
pression 0.045654296875
▁or 4.52734375
▁anx 0.044525146484375
iety 0.00107574462890625
▁among 1.5166015625
▁the 2.810546875
▁diverse 8.5625
▁groups 2.162109375
, 2.119140625
▁the 1.486328125
▁study 2.431640625
▁used 2.34375
▁multiple 4.84375
▁log 3.69140625
istic 0.118408203125
▁regression 0.1611328125
▁analysis 0.83544921875
▁and 2.595703125
▁chose 8.8203125
▁medical 6.67578125
▁mar 0.312255859375
iju 0.00621795654296875
ana 0.00019562244415283203
▁as 0.9091796875
▁the 1.2158203125
▁control 3.029296875
▁group 0.849609375
. 0.302978515625
▁The 1.13671875
▁research 2.490234375
ers 2.8984375
▁used 2.79296875
▁The 7.203125
▁De 4.83203125
pression 0.0640869140625
▁Module 8.953125
▁of 1.1962890625
▁the 0.387939453125
▁Pat 2.69921875
ient 0.00868988037109375
▁Health 0.141845703125
▁Question 0.1324462890625
naire 0.034912109375
▁and 3.068359375
▁the 0.80859375
▁General 1.69921875
ized 0.3125
▁An 0.2425537109375
x 0.000698089599609375
iety 0.00872802734375
▁Dis 0.7275390625
order 0.03857421875
▁Sc 1.865234375
ale 0.0675048828125
▁to 1.3779296875
▁interview 7.6015625
▁participants 2.017578125
, 3.65234375
▁evaluate 5.4609375
▁their 0.970703125
▁answers 6.0859375
, 0.650390625
▁and 0.1300048828125
▁conduct 4.68359375
▁the 2.337890625
▁study 2.20703125
. 0.301513671875
▁All 4.92578125
▁tools 8.5703125
▁in 5.10546875
▁the 0.544921875
▁form 4.41015625
▁of 0.06964111328125
▁question 1.8896484375
na 0.0543212890625
ires 0.00021958351135253906
▁and 2.537109375
▁scales 2.662109375
▁have 3.576171875
▁already 4.01953125
▁been 0.1300048828125
▁used 1.8466796875
▁and 2.421875
▁proved 4.8671875
▁their 3.078125
▁effic 3.33984375
acy 0.000621795654296875
▁for 3.390625
▁collect 5.765625
ing 0.034576416015625
▁analyt 8.4609375
ical 0.343994140625
▁data 0.361572265625
. 0.646484375
▁This 3.310546875
▁type 4.9765625
▁of 0.01197052001953125
▁study 1.6728515625
▁is 1.5380859375
▁the 2.9453125
▁most 1.65625
▁reve 9.0234375
aling 0.00086212158203125
▁and 1.0400390625
▁inclus 6.8125
ive 0.0034542083740234375
, 2.1328125
▁as 2.0703125
▁it 0.415771484375
▁contains 4.796875
▁direct 6.2109375
▁responses 4.66015625
▁from 0.837890625
▁a 3.91015625
▁large 1.203125
▁number 0.52978515625
▁of 0.0053253173828125
▁participants 1.5498046875
. 0.72900390625
▁It 2.609375
▁helps 4.578125
▁to 1.0634765625
▁system 8.0703125
at 1.3505859375
ize 0.0085296630859375
▁and 1.5517578125
▁class 3.794921875
ify 0.002147674560546875
▁distinct 9.0859375
▁kinds 6.48828125
▁of 0.03546142578125
▁information 4.9375
▁for 4.0625
▁subsequent 4.484375
▁un 7.765625
comp 5.46484375
licated 0.231689453125
▁services 11.328125
. 0.6533203125
▁The 1.3076171875
▁analysis 4.86328125
▁of 0.7607421875
▁any 8.4375
▁human 6.22265625
▁reaction 4.50390625
▁has 4.5078125
▁a 1.7998046875
▁high 4.12109375
▁potential 3.109375
▁of 1.6884765625
▁subject 7.3984375
iveness 4.01953125
▁and 1.2021484375
▁bias 3.017578125
, 1.490234375
▁especially 2.892578125
▁regarding 4.1953125
▁people 4.578125
▁in 3.869140625
▁severe 4.39453125
▁pain 0.273681640625
▁and 2.7421875
▁un 5.23046875
stable 2.65625
▁emot 0.9892578125
ional 0.219482421875
▁condition 2.388671875
. 0.1146240234375
▁Thus 3.822265625
, 0.02685546875
▁research 4.5859375
ers 0.5078125
▁can 3.552734375
▁compare 4.94140625
▁the 0.857421875
▁effects 3.00390625
▁of 0.07171630859375
▁medic 4.6875
ations 1.0537109375
▁on 1.8291015625
▁patients 2.05078125
▁of 4.17578125
▁diverse 4.85546875
▁age 3.0390625
▁groups 0.8408203125
, 1.1494140625
▁background 5.16796875
s 0.312744140625
, 0.0706787109375
▁physical 5.5625
▁conditions 1.869140625
, 0.100830078125
▁emot 4.4140625
ional 0.059600830078125
▁states 1.8134765625
, 0.11767578125
▁and 0.43798828125
▁so 3.412109375
▁on 1.046875
. 0.131103515625
▁Perhaps 8.5625
▁some 5.15234375
▁patients 2.322265625
▁tend 6.09765625
▁to 0.03753662109375
▁ex 5.58984375
agger 0.0213775634765625
ate 0.01494598388671875
▁their 0.88134765625
▁de 5.04296875
press 1.25
ive 0.477783203125
▁state 3.37890625
▁or 2.3125
▁vice 7.27734375
▁vers 0.01910400390625
a 0.001636505126953125
, 1.1875
▁de 7.30859375
- 5.015625
emph 1.4833984375
as 0.00677490234375
ize 0.341552734375
▁serious 6.47265625
▁difficulties 6.40625
. 0.900390625
▁Because 6.1484375
▁the 1.8818359375
▁survey 6.7265625
▁responses 6.84765625
▁were 1.6376953125
▁thoroughly 8.015625
▁anonymous 5.2109375
, 0.458251953125
▁the 1.3505859375
▁research 1.900390625
ers 0.381591796875
▁were 1.17578125
▁unable 2.8828125
▁to 0.006561279296875
▁carefully 8.859375
▁analyze 1.4970703125
▁each 4.01953125
▁patient 2.240234375
’ 26.453125
s 1.5947265625
▁reaction 4.203125
▁and 2.5703125
▁compare 3.55859375
▁it 1.1552734375
▁to 1.1630859375
▁the 0.8076171875
▁actual 5.7734375
▁states 7.65234375
▁of 0.5634765625
▁condition 7.2109375
. 0.435302734375
▁However 2.388671875
, 0.0023670196533203125
▁this 2.62109375
▁method 3.361328125
▁of 2.25390625
▁research 2.4765625
▁is 1.7705078125
▁way 9.4140625
▁more 0.4501953125
▁resource 7.23046875
- 2.384765625
int 1.439453125
ensive 0.01123809814453125
▁and 0.9892578125
▁energy 8.6484375
- 0.1099853515625
consum 0.42041015625
ing 0.018951416015625
. 1.087890625
▁Part 5.4453125
icip 0.16357421875
ants 0.06988525390625
▁were 0.9189453125
▁rec 2.228515625
ru 0.0005621910095214844
ited 2.110004425048828e-05
▁for 0.94775390625
▁six 0.348388671875
▁months 0.01214599609375
▁at 0.218017578125
▁two 0.036102294921875
▁major 0.0728759765625
▁pain 0.01132965087890625
▁relief 0.01087188720703125
▁cent 0.00708770751953125
ers 0.00783538818359375
▁in 0.0255889892578125
▁Israel 0.0212554931640625
. 0.0654296875
▁More 6.17578125
▁accurate 6.546875
▁answers 3.939453125
▁could 3.328125
▁be 0.6884765625
▁obtained 1.244140625
▁by 1.7919921875
▁professional 7.5859375
▁psych 2.541015625
olog 0.402099609375
ists 0.008941650390625
▁via 7.07421875
▁personal 4.53515625
▁communication 5.12109375
▁and 1.787109375
▁behavior 6.8515625
al 0.2578125
▁analysis 3.087890625
. 0.379638671875
▁All 4.25
▁patients 3.2265625
▁experienced 6.23828125
▁chron 2.96875
ic 0.006595611572265625
▁pain 0.047637939453125
▁for 4.2109375
▁at 1.0625
▁least 0.0015401840209960938
▁ 1.005859375
3 1.5888671875
▁months 0.474609375
. 1.0380859375
▁The 1.5595703125
▁study 2.052734375
▁included 3.1015625
▁ 0.94580078125
8 2.73046875
9 2.802734375
0 3.623046875
▁participants 1.455078125
, 1.3828125
▁of 1.7060546875
▁which 0.436767578125
▁ 0.1666259765625
4 1.755859375
7 2.4453125
4 2.751953125
▁( 2.17578125
5 0.118408203125
9 12.1484375
%) 0.85595703125
▁were 0.52392578125
▁treated 4.70703125
▁sole 6.8046875
ly 0.0033283233642578125
▁with 0.480224609375
▁op 0.98583984375
io 0.47119140625
ids 0.294921875
, 1.275390625
▁ 0.70751953125
3 1.1884765625
2 2.123046875
9 2.5
▁( 0.059661865234375
4 0.63720703125
1 1.1884765625
%) 0.310302734375
▁were 1.265625
▁treated 0.4296875
▁with 0.224365234375
▁MM 0.5068359375
, 0.2705078125
▁and 0.193603515625
▁ 0.133056640625
7 3.099609375
7 2.41015625
▁( 0.245849609375
8 4.125
. 0.4140625
6 3.18359375
%) 0.2281494140625
▁acquired 9.640625
▁both 1.2509765625
▁( 7.140625
Fe 9.3671875
ing 2.94921875
old 0.0526123046875
▁et 1.77734375
▁al 0.10211181640625
., 0.392333984375
▁ 0.0159912109375
2 0.3876953125
0 0.0006279945373535156
1 0.57958984375
7 2.181640625
). 0.245849609375
▁The 1.26953125
▁remaining 7.19140625
▁ten 7.84375
▁participants 1.6201171875
▁who 5.48828125
▁did 1.4638671875
▁not 0.00841522216796875
▁receive 1.583984375
▁ph 3.189453125
arma 0.037078857421875
ce 0.0018320083618164062
ut 2.181529998779297e-05
ical 0.0116424560546875
▁op 0.8994140625
io 0.08306884765625
ids 0.0297698974609375
▁and 1.7333984375
▁medical 2.421875
▁mar 0.06976318359375
iju 0.01038360595703125
ana 9.47713851928711e-05
▁were 1.4775390625
▁with 6.5859375
dra 0.10455322265625
wn 7.164478302001953e-05
▁from 0.33154296875
▁the 0.1397705078125
▁analysis 4.57421875
▁in 4.703125
▁the 1.1708984375
▁research 4.44140625
. 0.82470703125
▁Therefore 4.44140625
, 0.007770538330078125
▁it 3.580078125
▁is 0.9140625
▁not 2.541015625
▁possible 0.91455078125
▁to 0.0257720947265625
▁compreh 6.28125
ens 0.0264739990234375
ively 0.01183319091796875
▁compare 1.822265625
▁patients 4.43359375
▁taking 4.12890625
▁medic 3.86328125
ations 0.54150390625
▁with 0.91943359375
▁those 1.1728515625
▁who 1.1142578125
▁do 1.66796875
▁not 0.01204681396484375
. 0.82275390625
▁It 3.732421875
▁evaluated 11.2578125
▁the 0.5380859375
▁inter 6.83984375
dep 3.9609375
end 0.00330352783203125
ence 0.00704193115234375
▁of 0.52880859375
▁various 4.4609375
▁factors 1.4130859375
▁that 2.109375
▁affected 4.62109375
▁the 0.6298828125
▁physical 6.2734375
▁and 0.70361328125
▁emot 0.60009765625
ional 0.0003719329833984375
▁condition 1.1181640625
▁of 0.201171875
▁patients 0.6171875
▁experien 3.689453125
cing 5.9723854064941406e-05
▁chron 0.3076171875
ic 0.0006060600280761719
▁pain 0.0203094482421875
. 0.294921875
▁For 4.67578125
▁example 1.19921875
, 0.0158843994140625
▁the 1.439453125
▁survey 5.88671875
▁showed 3.20703125
▁that 0.264892578125
▁the 1.849609375
▁ratio 7.40234375
▁of 0.1241455078125
▁female 3.974609375
▁patients 0.98095703125
▁was 1.68359375
▁remark 9.5703125
ably 0.0008444786071777344
▁higher 0.65673828125
▁in 2.74609375
▁the 1.0703125
▁op 5.1328125
i 3.8046875
ates 0.274169921875
▁group 0.378662109375
▁compared 2.876953125
▁to 0.18505859375
▁the 0.56005859375
▁MM 0.405029296875
▁group 0.427978515625
. 0.4765625
▁The 1.775390625
▁study 2.548828125
▁conducted 4.734375
▁a 2.537109375
▁correlation 5.4453125
▁type 7.84375
▁of 0.70166015625
▁research 1.9140625
▁with 2.794921875
▁variable 8.390625
▁measures 4.39453125
. 1.763671875
▁In 3.2890625
▁turn 6.08203125
, 0.0121917724609375
▁people 6.21484375
▁on 5.375
▁op 2.044921875
i 0.796875
ates 0.01134490966796875
▁were 1.953125
▁more 1.94921875
▁likely 0.486572265625
▁to 0.06842041015625
▁report 3.0078125
▁major 5.85546875
▁de 0.450927734375
press 1.044921875
ive 0.002960205078125
▁dis 0.482666015625
orders 1.4677734375
. 1.990234375
▁For 4.828125
▁example 0.91259765625
, 0.012054443359375
▁it 3.701171875
▁included 5.51171875
▁compreh 8.1015625
ensive 0.07098388671875
▁so 7.91796875
cio 0.028472900390625
- 0.9189453125
dem 0.2548828125
ographic 0.07122802734375
▁data 1.5107421875
: 5.41796875
▁gender 1.6943359375
, 0.1187744140625
▁age 0.319091796875
, 0.10626220703125
▁country 4.03515625
, 1.169921875
▁type 4.078125
▁of 0.0782470703125
▁residence 4.578125
▁( 3.33984375
urban 2.29296875
/ 2.837890625
r 0.060455322265625
ural 0.0008397102355957031
), 0.418212890625
▁years 6.1015625
▁of 0.2454833984375
▁education 0.86572265625
, 0.2049560546875
▁and 1.96484375
▁employ 3.818359375
ment 0.009246826171875
▁status 0.476806640625
. 0.26123046875
▁The 1.55859375
▁question 4.8671875
na 2.009765625
ires 0.00061798095703125
▁used 3.03125
▁different 6.359375
▁variable 8.6796875
▁measures 1.06640625
▁to 1.6435546875
▁collect 1.9404296875
▁information 2.25
. 1.9267578125
▁Pat 4.79296875
ients 0.08050537109375
▁were 1.3486328125
▁also 3.205078125
▁asked 1.134765625
▁about 1.419921875
▁their 0.6845703125
▁medical 3.458984375
▁history 0.62841796875
▁over 8.3515625
▁the 0.241943359375
▁years 3.703125
▁and 1.9853515625
▁the 1.9658203125
▁current 3.537109375
▁presence 5.97265625
▁of 0.06683349609375
▁any 2.505859375
▁severe 4.421875
▁dise 1.81640625
ases 0.00016546249389648438
▁such 4.1171875
▁as 0.006397247314453125
▁heart 2.48828125
▁failure 2.025390625
, 0.248779296875
▁di 1.875
ab 0.00327301025390625
etes 0.00458526611328125
, 0.1507568359375
▁ar 3.873046875
th 1.3994140625
rit 0.07537841796875
is 0.1470947265625
, 0.049957275390625
▁and 1.615234375
▁so 0.91064453125
▁on 0.06060791015625
. 0.070556640625
▁The 1.4560546875
▁third 7.0703125
▁measure 5.67578125
▁of 1.6865234375
▁the 1.099609375
▁question 3.791015625
naire 0.10296630859375
▁was 1.095703125
▁indicated 9.84375
▁by 0.9208984375
▁information 6.29296875
▁on 1.5546875
▁any 4.9609375
▁twelve 13.046875
- 1.119140625
month 0.92919921875
▁and 5.546875
▁lifetime 2.982421875
▁drug 4.58203125
▁and 3.08984375
▁alco 0.10601806640625
hol 0.0003559589385986328
▁consumption 2.82421875
. 0.51220703125
▁In 3.083984375
▁addition 1.21484375
, 0.172119140625
▁the 1.07421875
▁record 7.9375
▁included 2.458984375
▁a 2.6953125
▁pain 7.12890625
▁measurement 4.58203125
▁scale 1.205078125
▁from 3.47265625
▁ 0.4619140625
0 0.499755859375
▁to 0.533203125
▁ 0.01220703125
1 0.08966064453125
0 0.12420654296875
▁to 4.78125
▁evaluate 1.705078125
▁dis 5.75
com 0.331298828125
fort 0.0024089813232421875
▁feelings 7.3203125
▁during 3.453125
▁the 0.90478515625
▁last 1.6865234375
▁month 1.5615234375
. 0.29248046875
▁Among 6.7421875
▁all 2.642578125
▁participants 1.8603515625
▁in 3.703125
▁the 0.270751953125
▁study 0.6806640625
, 0.0975341796875
▁ 0.6640625
4 1.97265625
2 2.599609375
. 1.548828125
2 2.224609375
% 0.2489013671875
▁suffered 4.4609375
▁from 0.16455078125
▁de 1.828125
pression 0.137451171875
, 1.1328125
▁and 1.6201171875
▁ 0.160400390625
3 1.708984375
7 2.3046875
% 2.5078125
▁experienced 2.3203125
▁excess 7.76171875
ive 0.12237548828125
▁anx 0.3349609375
iety 0.0027217864990234375
. 0.343017578125
▁The 1.4033203125
▁pl 11.0234375
ur 2.255859375
ality 0.004238128662109375
▁of 0.2080078125
▁de 3.68359375
press 1.2958984375
ive 0.0257415771484375
▁dis 1.5537109375
orders 0.063720703125
▁among 3.4453125
▁patients 1.1708984375
▁in 3.6640625
▁the 0.47265625
▁op 2.0390625
i 1.6728515625
ates 0.0098724365234375
, 6.625
▁medical 3.041015625
▁mar 0.03778076171875
iju 0.019439697265625
ana 3.921985626220703e-05
, 0.08758544921875
▁and 0.0838623046875
▁mixed 6.88671875
▁OP 8.53125
MM 5.79296875
▁groups 0.6630859375
▁number 8.21875
ed 0.039581298828125
▁ 0.149658203125
5 2.130859375
7 2.45703125
. 0.2340087890625
1 2.298828125
%, 0.262451171875
▁ 0.00574493408203125
2 2.958984375
2 2.384765625
. 0.1844482421875
3 2.248046875
%, 0.12200927734375
▁and 0.04205322265625
▁ 0.0037212371826171875
5 3.1328125
1 2.455078125
. 0.362548828125
4 2.140625
%, 0.312744140625
▁respectively 0.0097503662109375
. 0.29345703125
▁The 1.375
▁pl 4.25
ur 0.1400146484375
ality 0.00012981891632080078
▁of 0.046417236328125
▁anx 0.71728515625
iety 0.0113677978515625
▁contained 11.3046875
▁ 0.7353515625
4 1.5888671875
8 2.333984375
. 0.08966064453125
4 2.28515625
% 0.62890625
▁among 1.3115234375
▁OP 6.55859375
▁patients 9.28125
, 0.38818359375
▁ 0.11065673828125
2 1.48046875
1 2.345703125
. 0.221923828125
5 2.521484375
% 0.021270751953125
▁among 0.449951171875
▁MM 0.271240234375
▁patients 0.318359375
, 0.0170135498046875
▁and 0.0171051025390625
▁ 0.033203125
3 1.265625
8 2.564453125
. 0.246826171875
7 2.294921875
% 0.0239105224609375
▁among 0.2154541015625
▁OP 3.720703125
MM 0.12298583984375
▁participants 3.736328125
. 0.2164306640625
▁Pat 4.87109375
ients 0.0384521484375
▁who 2.439453125
▁took 3.021484375
▁strong 7.51171875
▁op 1.912109375
i 1.458984375
ates 0.007221221923828125
▁were 1.75
▁t 8.609375
ended 1.0771484375
▁to 0.021453857421875
▁place 9.84375
▁their 3.716796875
▁pain 2.6640625
▁on 3.4453125
▁a 0.75537109375
▁scale 2.125
▁of 0.6396484375
▁ 0.3876953125
9 2.978515625
▁to 1.3046875
▁ 0.0232696533203125
1 0.035003662109375
0 0.1708984375
▁( 2.755859375
Fe 1.6220703125
ing 0.1839599609375
old 0.0015020370483398438
▁et 0.050201416015625
▁al 0.006805419921875
., 0.01561737060546875
▁ 0.00244140625
2 0.0012598037719726562
0 4.875659942626953e-05
1 0.004413604736328125
7 0.0196075439453125
). 0.1312255859375
▁They 4.3125
▁were 1.650390625
▁also 1.66015625
▁an 8.09375
gu 5.1796875
ished 0.05755615234375
▁em 8.203125
otion 0.0216522216796875
ally 0.007312774658203125
▁and 1.2529296875
▁react 6.91796875
ed 0.12255859375
▁rad 9.3515625
ically 0.0035114288330078125
▁neg 5.14453125
atively 0.0010671615600585938
▁to 0.464599609375
▁almost 5.23046875
▁all 1.2431640625
▁survey 8.515625
▁questions 0.849609375
. 0.36474609375
▁Pat 3.978515625
ients 0.01708984375
▁who 1.548828125
▁took 1.5498046875
▁only 5.50390625
▁MM 0.9794921875
▁or 3.51953125
▁mixed 4.08203125
▁medic 2.78515625
ations 0.484130859375
▁course 12.28125
▁had 2.486328125
▁a 1.2177734375
▁significantly 2.51171875
▁more 3.96875
▁stable 3.580078125
▁emot 1.119140625
ional 0.0067901611328125
▁state 1.0849609375
▁and 1.5615234375
▁cop 5.57421875
ed 1.251953125
▁with 0.662109375
▁pain 1.4599609375
▁more 1.7177734375
▁manage 6.70703125
able 2.39453125
. 0.6171875
▁One 5.73828125
▁of 1.041015625
▁the 0.037689208984375
▁major 2.94140625
▁limitations 3.40625
▁is 3.3125
▁the 0.6064453125
▁ins 4.70703125
u 0.04571533203125
fficient 0.12359619140625
ly 4.4375
▁high 2.869140625
▁response 3.0078125
▁rate 0.183349609375
, 2.095703125
▁ 4.91015625
5 2.0
7 1.8330078125
% 2.046875
▁instead 6.984375
▁of 0.010498046875
▁ 0.55078125
7 1.7080078125
0 1.6591796875
% 1.2373046875
▁( 1.4716796875
Fe 0.31689453125
ing 0.06744384765625
old 0.0015211105346679688
▁et 0.00801849365234375
▁al 0.0028972625732421875
., 0.00962066650390625
▁ 0.001911163330078125
2 0.0005736351013183594
0 5.316734313964844e-05
1 0.0015668869018554688
7 0.00908660888671875
). 0.0887451171875
▁It 3.078125
▁can 3.541015625
▁be 0.476806640625
▁fairly 7.69140625
▁explained 3.0625
▁by 0.27099609375
▁the 0.37548828125
▁weak 7.7734375
▁focus 7.25
▁of 0.62353515625
▁respond 5.60546875
ents 0.12451171875
▁who 3.408203125
▁have 3.75
▁overcome 7.99609375
▁severe 2.486328125
▁pain 0.70361328125
▁sens 8.1171875
ations 1.4990234375
▁and 1.328125
▁de 4.0625
press 1.671875
ive 0.291748046875
▁episodes 3.841796875
. 0.6884765625
▁It 3.185546875
▁is 1.16796875
▁not 2.74609375
▁clear 4.34375
▁how 1.7607421875
▁to 3.40625
▁use 5.20703125
▁these 3.107421875
▁statistics 4.00390625
, 2.859375
▁as 1.6630859375
▁they 1.4619140625
▁still 6.19921875
▁may 5.05859375
▁be 1.4921875
▁relevant 5.6953125
▁for 1.4482421875
▁the 1.9443359375
▁overall 4.94140625
▁analysis 3.4609375
. 1.2236328125
